Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan K Shields

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Infectious Diseases and Therapy|August 28, 2024
Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysisRyan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniaeMeredith G Jernigan, Ellen G Press, M Hong Nguyen, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposureRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Mutations in <i>bla</i><sub>KPC-3</sub> That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-LactamasesGhady Haidar, Cornelius J Clancy, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|December 27, 2025
Clinical outcomes of metronidazole dosing strategies in obese patients with Bacteroides bloodstream infectionsSunish Shah, Rachel V Marini, Dayna McManus, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 25, 2022
Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical TrialsPatrice Nordmann, Ryan K Shields, Yohei Doi, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2019
Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for <i>FKS</i>-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and OsteomyelitisWilliam F Wright, Nika Bejou, Ryan K Shields, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2024
Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemiaSunish Shah, Lloyd G Clarke, Justin Ludwig, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complexYuriko Fukuta, Lloyd G Clarke, Ryan K Shields, et al.
World Neurosurgery|April 6, 2023
Microbiologic and Clinical Description of Postoperative Central Nervous System Infection After Endoscopic Endonasal SurgerySunish Shah, Joseph Durkin, Karin E Byers, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Infectious Diseases and Therapy|August 28, 2024
Correction to: Ceftazidime‑Avibactam in the Treatment of Patients with Bacteremia or Nosocomial Pneumonia: A Systematic Review and Meta‑analysisRyan K Shields, Juan P Horcajada, Shweta Kamat, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniaeMeredith G Jernigan, Ellen G Press, M Hong Nguyen, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposureRyan K Shields, M Hong Nguyen, Ellen G Press, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Mutations in <i>bla</i><sub>KPC-3</sub> That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-LactamasesGhady Haidar, Cornelius J Clancy, Ryan K Shields, et al.
International Journal of Antimicrobial Agents|December 27, 2025
Clinical outcomes of metronidazole dosing strategies in obese patients with Bacteroides bloodstream infectionsSunish Shah, Rachel V Marini, Dayna McManus, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|January 25, 2022
Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical TrialsPatrice Nordmann, Ryan K Shields, Yohei Doi, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2019
Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for <i>FKS</i>-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and OsteomyelitisWilliam F Wright, Nika Bejou, Ryan K Shields, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2024
Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemiaSunish Shah, Lloyd G Clarke, Justin Ludwig, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Lack of seasonality in the occurrence of multidrug-resistant Acinectobacter baumannii complexYuriko Fukuta, Lloyd G Clarke, Ryan K Shields, et al.
World Neurosurgery|April 6, 2023
Microbiologic and Clinical Description of Postoperative Central Nervous System Infection After Endoscopic Endonasal SurgerySunish Shah, Joseph Durkin, Karin E Byers, et al.
Pageof 20